Phase II trial of hu14.18-IL2 for patients with metastatic melanoma.
Albertini MR; Hank JA; Gadbaw B; Kostlevy J; Haldeman J; Schalch H; Gan J; Kim K; Eickhoff J; Gillies SD; Sondel PM; Cancer Immunology, Immunotherapy: CII, 2012, vol. 61, issue 12, p 2261, ISSN 14320851. ISBN 14320851.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef